88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026 Earnings Conference Call to be Held on August 20, 2026 ... 2026-08-05T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing SAN DIEGO , Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused ... 2026-08-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer SHANGHAI , Aug. 5, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor ... 2026-08-05T Health Care/Hospital Medical/Pharmaceuticals
Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisram cements its strategic leadership across APAC ... 2026-08-05T Cosmetics & Personal Care Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results CHANGZHOU, China , Aug. 5, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), ... 2026-08-05T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
NIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance Now commercially available, the medium cut-off dialyzer expands access to enhanced middle molecule removal through existing dialysis infrastructure ... 2026-08-04T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
72 patient multi-indication trial approved to fast track TRP-8803 commercialisation Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across ... 2026-08-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth SHANGHAI , Aug. 4, 2026 /PRNewswire/ -- AsymBio , a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock codes: 002821.SZ / 6821.HK), ... 2026-08-04T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics ... 2026-08-04T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite Piramal Pharma Solutions has added a new spray drying suite with Band 5 containment capacity at its dedicated peptide facility in Turbhe, India, equipped with its own air handling units, nitrogen supply, ... 2026-08-04T Biotechnology Chemical Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved